We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry Survey on Q7A Reveals Areas of Confusion
Industry Survey on Q7A Reveals Areas of Confusion
March 7, 2005
Pharmaceutical companies find that out of all the topics covered in the Q7A GMP Guidance for Active Pharmaceutical Ingredients (API), the areas that cause the most confusion are validation, the definition of "blending," reprocessing and the definition of "starting material," according to a survey of eight PhRMA member companies.